Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Name Common Trade Name(s)sort icon Classification Date Marketed in Canada (yyyy/mm/dd)
Phosphate Effervescent Phosphate Sandoz 2017/01/01
Aminophylline Phyllocontin Bronchodilator 2010
Doravirine Pifeltro NNRTI 2018/11/15
Alpelisib Piqray Antineoplastic agent 2020/03/11
Pomalidomide Pomalyst Antineoplastic agent; immunmodulator 2014/02/24
Tetracaine Pontocaine (spinal anesthesia) Local anesthetic
Ponesimod Ponvory Sphingosine 1-phosphate receptor modulator 2021/04/28
Dexmedetomidine Precedex Alpha-2 adrenergic agonist 2010/02/24
Vitamin C Prevegyne Gynecological antiinfectives and antiseptics 2011/01
Pneumococcal 13-valent conjugate vaccine Prevnar 13 Vaccine 2010/03/17
Letermovir Prevymis Antiviral agent 2017/12/20
Lumiracoxib Prexige COX-2 inhibitor 2006/11
Darunavir Prezista Antiviral agent 2006
Desvenlafaxine Pristiq Antidepressant 2009/03/02
Buprenorphine Probuphine Opiate partial agonist 2018/04/18
Denosumab Prolia RANK Ligand inhibitor 2010/08/10
Propofol Propofol Injection Anesthetic, sedative 2010/06/01
Saxagliptin + dapagliflozin Qtern Oral antihyperglycemic agent 2018/03/20
Edaravone Radicava Treatment for amyotrophic lateral sclerosis 2019/10/29
Silodosin Rapaflo Alpha-1 adrenergic blocker 2012/03/05
Aliskiren and hydrochlorothiazide Rasilez HCT Renin inhibitor and diuretic 2009/09
Prucalopride Resotran Enterokinetic agent 2012/01/13
Cyclosporine Restasis Topical immunomodulator with anti-inflammatory effects 2010/10
Sildenafil citrate Revatio IV cGMP-Specific Phosphodiesterase Type 5 Inhibitor 2010/08/31
Lenalidomide Revlimid Antineoplastic agent
Eltrombopag Revolade Thrombopoietin receptor antagonist 2011/0404
Brexpiprazole Rexulti Antipsychotic agent 2017/04/20
Upadacitinib Rinvoq Disease-modifying antirheumatic agent 2020/01/16
Calcitriol Rocaltrol oral solution Vitamin D analogue
Ivermectin Rosiver Topical rosacea therapy 2015/05/25
Entrectinib Rozlytrek Antineoplastic agent
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Semaglutide Rybelsus Incretin mimetic 2020/04/19
Tolvaptan Samsca Vasopressin V2 receptor antagonist 2011/09/22
Asenapine Saphris Atypical antipsychotic 2012/03/16
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Syndicate content